Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation

Molecular and Cellular Biochemistry

Volumn 247, Issue 1-2, 2003, Pages 55-60

  Oliva, Adriana ^a   Borriello, Adriana ^a   Zeppetelli, Stefania ^a   Di Feo, Angelo ^a   Cortellazzi, Pilade ^a   Ventriglia, Vega ^a   Criscuolo, Maria ^a   Zappia, Vincenzo ^a   Della Ragione, Fulvio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cdk inhibitors; Hemopoiesis; Leukemia treatment; Mesenchymal stem cells; p16INK4A; p27Kip1; Retinoic acid

Indexed keywords

ANTILEUKEMIC AGENT; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16; PROTEIN P27; RETINOBLASTOMA PROTEIN; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; MITOSIS INHIBITION; MOLECULAR DYNAMICS; OSTEOBLAST; PROTEIN PHOSPHORYLATION; UPREGULATION;

BONE MARROW CELLS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; HUMANS; MESODERM; PHENOTYPE; RETINOBLASTOMA PROTEIN; STEM CELLS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0038081046     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024192719178     Document Type: Article

References (37)

1. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 27: 671-674, 1997
2. Wakitani S, Saito T, Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 17-26, 1995
3. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247-256, 2000
4. Woodbury D, Schwarz EJ, Prockop DJ, Black IB: Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364-70, 2000
5. Levesque JP, Haylock DN, Simmons PJ: Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors. Blood 88: 1168-1176, 1996
6. Fernandez M, Minguell JJ: Adhesive interactions in the hematopoietic system: Regulation by cytokines. Proc Soc Exp Biol Med 212: 313-323, 1996
7. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL: Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9: 841-848, 2000
8. Huss R: Perspectives on the morphology and biology of CD34-negative stem cells. J Hematother Stem Cell Res 9: 783-793, 2000
9. Niederreither K, Subbarayan V, Dolle P, Chambon P: Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat Genet 21: 444-448, 1999
10. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T: Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290: 2140-2144, 2000
11. Krezel W, Ghyselinck N, Samad TA, Dupe V, Kastner P, Borrelli E, Chambon P: Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279: 863-867, 1998
12. Kastner P, Mark M, Leid M, Gansmuller A, Chin W, Grondona JM, Decimo D, Krezel W, Dierich A, Chambon P: Abnormal spermatogenesis in RXR beta mutant mice. Gene Dev 10: 80-92, 1996
13. Massaro GD, Massaro D, Chan WY, Clerch LB, Ghyselinck N, Chambon P, Chandraratna RA: Retinoic acid receptor-beta: An endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol Genomics 4: 51-57, 2000
14. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, French S, Mangelsdorf DJ, Sucov HM: Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20: 4436-4444, 2000
15. Imai T, Jiang M, Kastner P, Chambon P, Metzger D: Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc Natl Acad Sci USA 98: 4581-4586, 2001
16. Dupe V, Ghyselinck NB, Thomazy V, Nagy L, Davies PJ, Chambon P, Mark M: Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev Biol 208: 30-43, 1999
17. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H: Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 7: 680-686, 2001
18. Hassan HT: Synergism between differentiation agents: Preclinical and clinical studies in myeloid leukaemia. In: R.A. Rifkind (ed). The Pharmacology of Cell Differentiation. Elsevier Science Publishers B.V, Amsterdam, 1993, pp 277-294
19. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH: All-trans retinoic acid in acute promyelocytic leukaemia. N Engl J Med 337: 1021-1028, 1997
20. Jacobsen SE, Fahlman C, Blomhoff HK, Okkenhaug C, Rusten LS, Smeland EB: All-trans and 9-cis retinoic acid: Potent direct inhibitors of primitive murine haematopoietic progenitors in vitro. J Exp Med 179: 1665-1670, 1994
21. Smeland EB, Rusten L, Jacobsen SE, Skrede B, Blomhoff R, Wang MY, Funderud S, Kvalheim G, Blomhoff HK: All-trans retinoic acid directly inhibits G-CSF-induced proliferation of CD34 positive human haematopoietic progenitor cells. Blood 84: 2940-2945, 1994
22. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA: Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2: 83-92, 1974
23. Oliva A, Marrone G, Della Ragione F, Riccio V, Palumbo R, Rossano F, Zappia V: Isolation and characterization of human embryonic osteoblasts. Calc Tissue Int 51: 356-362, 1992
24. Oliva A, Della Ragione F, Salerno A, Riccio V, Tartaro G, Cozzolino A, D'Amato S, Pontoni G. Zappia V: Biocompatibility studies on glass ionomer cements by primary cultures of human osteoblasts. Biomaterials 17: 1351-1356, 1996
25. Nicoletti I, Migliorati G, Pagliacci MC, Grignai F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Met 139: 271-279, 1991
26. Dulic V, Kaufmmann WK, Wilson AJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023, 1994
27. Della Ragione F, Russo GL, Oliva A, Mastropietro S, Mancini A, Borrelli A, Casero RA, Iolascon A, Zappia V: 5′-Deoxy-5′-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines. Oncogene 10: 827-833, 1995
28. Della Ragione F, Russo GL, Oliva A, Mercurio C, Mastropietro S, Della Pietra, V, Zappia V: Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines. J Biol Chem 271: 15942-15949, 1996
29. Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD: Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Exp Cell Res 258: 322-331, 2000
30. Dirks PB, Patel K, Hubbard SL, Ackerley C, Hamel PA, Rutka JT: Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Oncogene 15: 2037-2048, 1997
31. Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH: Induction of p21 (WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol Cell Biol 19: 3916-3928, 1999
32. Dow R, Hendley J, Pirkmaier A, Musgrove EA, Germain D: Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2. J Biol Chem 276: 45945-45951, 2001
33. Hara E, Smith R, Parry D, Hidetoshi T, Stone S, Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867, 1996
34. Quelle DE, Zindy F, Ashmun RA, Sherr CJ: Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000, 1995
35. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peter G: The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17: 5001-5014, 1998
36. Tam SW, Shay JW, Pagano M: Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res 54: 5816-5820, 1994
37. Della Ragione F, Borriello A, Mastropietro S, Della Pietra V, Monno F, Gabutti V, Locatelli F, Bonsi L, Bagnara GP, Iolascon A: Expression of G1-phase cell cycle genes during hematopoietic lineage, Biochem Biophys Res Commun 231: 73-76, 1997.